Delivery Order SPE2DB24D1021-SPE2DB25FEUCC

Award Date 2/19/25
Potential Completion Date 2/20/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of JANUVIA 100 MG TABLET 90S. The contract has a ceiling value of $1,819.10 and is a Firm Fixed Price Delivery Order, with a period of performance through February 6, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,819.10 firm fixed-price delivery order is for the provision of JANUVIA 100 MG TABLET 90S, with a performance period through January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,025.29 firm fixed price delivery order is for the supply of JANUVIA 100 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of November 29, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,343,398 units of the drug JANUVIA 100 MG TABLET 1000S. The firm-fixed-price contract has a ceiling value of $15,484.74 and an ultimate completion date of November 6, 2024. This contract is a delivery order awarded under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $13,841.92, is a Firm Fixed Price Delivery Order for the supply of JANUVIA 100 MG TABLET 1000S. The contract has an ultimate completion date of July 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the procurement of JANUVIA 50 MG TABLET 90S. The contract has a ceiling value of $6,079.34 and is a firm fixed-price delivery order with a period of performance through May 22, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $11,113.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of JANUVIA 100 MG TABLET 1000S, a pharmaceutical product, over a period ending on January 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $1,091.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of JANUVIA 100 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of January 14, 2025 and is a firm fixed-price contract. The award was not designated with a set-aside requirement, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,742.18, is for the delivery of JANUVIA 100 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of January 16, 2025 and is structured as a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,775 firm-fixed-price delivery order is for JANUVIA 100 MG TABLET 90S, a pharmaceutical product. The contract has a period of performance through September 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FEUCC
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of JANUVIA 100 MG TABLET 90S. The contract has a ceiling value of $1,819.10 and is a Firm Fixed Price Delivery Order, with a completion date of February 20, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award was not designated with a set-aside requirement, indicating open competition.

Generated 5/21/25, 10:30 AM